About Technology Issues FAQ

Links

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.